Catalym
Senior Safety Physician
Senior Safety Physician bei CatalYm in Martinsried bei München. Verantwortung für die strategische Ausrichtung der klinischen Arzneimittelsicherheit und Sicherheitsstrategie in der klinischen Entwicklung.
Kostenlos. Atlas passt deinen Lebenslauf an genau diese Stelle an und sucht weiter passende Jobs für dich.
Ohne Optimierung bewerbenAtlas Vorteil
- Lebenslauf und Anschreiben passend zu genau dieser Stelle geschrieben, nicht aus der Schublade.
- Match-Score mit Begründung Atlas zeigt dir, wie gut die Stelle zu dir passt, und sagt ehrlich, was passt und was nicht.
- Alles im Blick im Tracking siehst du, wo jede Bewerbung steht, vom Versand bis zum Gespräch.
Das bietet der Arbeitgeber
- Flexible Arbeitszeiten
Stellenbeschreibung
Your mission In this role you will lead the strategic direction for Clinical Drug Safety, overseeing the evaluation of the safety profile of our products throughout their lifecycle. You will also shape and implement safety standards and drive the overall safety strategy supporting our clinical development programs.
Your profile
MD with several years of practical experience in patient care. More than 5 years of experience in clinical Safety with global trials in the pharmaceutical industry (preferably including biologics) Familiar with Safety relevant ICH Guidelines and ICHE6(R3) Familiar with EU and FDA Safety reporting requirements Fluent in English (writing and speaking) Based in Munich area with ca.
2 days per week in the office Why us? Contribute directly to the success of cutting-edge oncology programs. Be part of an agile, collaborative biotech environment with visible impact. Enjoy flexibility, ownership, and professional growth within a supportive culture. CatalYm is a biotech company based in Martinsried near Munich, developing innovative immunotherapies to transform cancer patients’ lives by effectively engaging their own immune systems to combat this malignant disease.
We are now advancing to Phase 2b studies to confirm visugromab, our lead antibody, that has demonstrated durable anti-tumor efficacy with long-lasting objective responses in relapsed and refractory metastatic solid tumor patients in combination with anti-PD-1 treatment. Our mission is to rapidly bring our next-generation immuno-oncology products to patients in need.
Are you ready to board the fast-accelerating visugromab train in Martinsried? Then join us!